About Fermelanta
Fermelanta is a company based in Nonoichi (Japan) founded in 2022 by Hiromichi Minami, Akira Nakagawa, and Shogo Fukizaki. Fermelanta has raised $21.43 million across 3 funding rounds from investors including Plug and Play Tech Center, Beyond Next Ventures and Keio Innovation Initiative. Fermelanta operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter Nonoichi, Japan
- Founders Hiromichi Minami, Akira Nakagawa, Shogo Fukizaki
- SectorsChemicals & MaterialsHealthcare
- Email••••••••
- Website fermelanta.com
- Social LinkedIn
- Total Equity Funding$21.43M (USD)
in 3 rounds
- InvestorsPlug and Play Tech Center
& 9 more
Funding Insights of Fermelanta
Fermelanta has successfully raised a total of $21.43M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.43M
- Total Rounds 3
- First Round $1.43M
(Jun 2023)
- Investors Count 10
All 3 funding rounds of Fermelanta with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | – | Grant | – | – | |
| Aug 2025 | $20M | Series A | – | – | |
| Jun 2023 | $1.43M | Seed | – | Beyond Next Ventures, Angel Bridge | – |
10 investors in total: 10 institutional.
Investors in Fermelanta
Fermelanta has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Plug and Play Tech Center, Beyond Next Ventures and Keio Innovation Initiative.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges. | 2014 | beyondnextventures.com | Tokyo, Japan | |
Venture capital investments are made in innovative startups by Angel Bridge. | – | angelbridge.jp | Japan | |
Startups are accelerated and invested in across multiple tech sectors. | 2006 | plugandplaytechcenter.com | Sunnyvale, United States | |
- | – | smbc-vc.co.jp | - | |
Stage-agnostic investments in Japanese tech and life sciences are made. | 2015 | keio-innovation.co.jp | Tokyo, Japan | |
Venture capital is invested in AI, energy, and various sectors. | – | mucap.co.jp | Tokyo, Japan | |
- | – | miyakocapital.com | - | |
Tech & Life sciences focused VC firm investing primarily in Japan | – | umi.co.jp | Tokyo, Japan | |
A private equity fund management company is operated. | – | nc-cap.co.jp | Japan | |
- | – | nedo.go.jp | - |
Investor details for Fermelanta
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Fermelanta
3 people are tracked at Fermelanta (3 in leadership).
| Name | Role | Group |
|---|---|---|
Hiromichi Minami | Co-Founder & CSO | Leadership |
Akira Nakagawa | Co-Founder & CTO | Leadership |
Shogo Fukizaki | Co-Founder & CEO | Leadership |
Complete people profiles for Fermelanta
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Fermelanta
3 dated milestones of Fermelanta across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Fermelanta is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Grant,.
Competitors of Fermelanta
Fermelanta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amyris.com | 2003 | Emeryville, United States | $487.2M | 747 | Developer of renewable products for industrial solutions | |
| syngenta.com | 2000 | Basel, Switzerland | – | – | Crop protection solutions and hybrid seeds are provided for farming. | |
| askbio.com | 2001 | Durham, United States | $235M | – | Gene and protein therapies are developed for treating various diseases. | |
| ginkgobioworks.com | 2008 | Boston, United States | $795.75M | 1,218 | Gene editing-based cultured ingredients are provided for agriculture. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| twistbioscience.com | 2013 | San Francisco, United States | $245.81M | 919 | Synthetic DNA is synthesized via a semiconductor-based platform. | |
| asimov.com | 2017 | Boston, United States | $209.4M | 87 | Provider of integrated suite for advanced genetic design and manufacturing | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| synlogictx.com | 2013 | Cambridge, United States | $34.4M | 85 | Engineered microbes are developed as programmable therapeutics for metabolic disorders. |
Detailed competitors of Fermelanta
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Fermelanta
The website of Fermelanta (fermelanta.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 36% vs previous month
Websites whose visitors overlap most with Fermelanta. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| techblitz.com | 100% | – | #1,233,948 | View details |
Latest news on Fermelanta
Complete news archive for Fermelanta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Fermelanta
10 companies that operate in the same segment as Fermelanta (Chemicals Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Microbe-based plant protection products and yield optimization services are provided. | 2013 | Boston, Massachusetts, United States | USD 1.4 B | – | – | |
Plant-based biopesticides are developed for agricultural applications by Terramera. | 2010 | Vancouver, British Columbia, Canada | USD 64.94 M | USD 3.42 M | 16 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
Developr of bio-based products and natural compounds for biotechnological solutions | 1993 | Zwingenberg, Hesse, Germany | USD 5.38 M | – | – | |
Sustainable bio-based chemicals are manufactured using a proprietary platform. | 2016 | Houston, Texas, United States | USD 686.05 M | – | – | |
Biological insecticides and pesticides are developed from spider peptides. | 2001 | Kalamazoo, Michigan, United States | USD 286.68 M | – | – | |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied. | 2010 | Berkeley, California, United States | USD 618.08 M | – | – | |
Instruments and software for color calibration are developed by Datacolor. | 1970 | Lawrenceville, United States | – | USD 781.59 K | 20 | |
Green acids are produced from microbes via synthetic biology. | 2010 | Emeryville, California, United States | USD 51.77 M | – | – | |
Phytochemicals are developed using microbial fermentation processes. | 2011 | Cambridge, Massachusetts, United States | USD 115.93 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fermelanta
Fermelanta was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Fermelanta is headquartered in Nonoichi, Japan. It is registered at Nonoichi, Ishikawa, Japan.
Shogo Fukizaki is the current CEO of Fermelanta. They have also founded this company.
Fermelanta is a funded company, having raised a total of $21.43M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.43M, raised on Jun 2023.
Fermelanta was founded in 2022 in Nonoichi, Japan, as a biotech firm. Microbial fermentation processes are employed to generate plant-based chemicals, with a focus on secondary metabolites. These compounds are applied in medicines, cosmetics, and health foods. Operations center on sustainable production methods within the biotechnology sector, supporting various industrial applications.
Fermelanta has 10 investors. Key investors include Plug and Play Tech Center, Beyond Next Ventures, Keio Innovation Initiative, Angel Bridge, and SMBC Venture Capital.